The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
NCT02791698 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2019-01-18
Summary
The investigators will conduct a prospective study, in which they will determine sensitivity, specificity and diagnostic accuracy of late evening urinary free cortisol concentration/creatinine and hair cortisol in differentiating Cushing's syndrome from Pseudo-Cushing's syndrome.
Conditions
- Cushing Syndrome
Sponsors & Collaborators
-
Bnai Zion Medical Center
lead OTHER_GOV
Principal Investigators
-
Leonard Saiegh, M.D. · Bnai Zion Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2019-05-31
- Completion
- 2020-05-31
Countries
- Israel
Study Locations
More Related Trials
-
Study of Depression, Peptides, and Steroids in Cushing's Syndrome
NCT00004334 ·Status: UNKNOWN
-
Cushing's Syndrome Before and After Treatment (CORRECT)
NCT05521529 ·Status: RECRUITING
-
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
NCT02922257 ·Status: COMPLETED
-
Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids
NCT03229395 ·Status: COMPLETED
-
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 ·Status: RECRUITING
-
Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
NCT02310269 ·Status: COMPLETED
-
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
NCT02804750 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Endogenous Cushing's Syndrome
NCT01838551 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
Cortisol Response to Adrenocorticotrophin (ACTH) in Acute Stress
NCT00493389 ·Status: UNKNOWN ·Phase: NA
-
Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
NCT01459237 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Long-term Cardiovascular Risk in Cured Cushing's Patients
NCT00881283 ·Status: TERMINATED
-
Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
NCT03145285 ·Status: UNKNOWN ·Phase: PHASE2
-
Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test
NCT00851942 ·Status: COMPLETED ·Phase: PHASE4
-
Standardized 1µg Adrenocorticotropic Hormone Stimulation Test, and Salivary Cortisol Concentration During the Test
NCT02413944 ·Status: COMPLETED ·Phase: PHASE4
-
DDAVP for Pituitary Adenoma
NCT04569591 ·Status: RECRUITING ·Phase: NA
-
Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
NCT02297945 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
NCT00171951 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
NCT00682084 ·Status: TERMINATED
-
Cushing's Disease Complications
NCT02568982 ·Status: COMPLETED
-
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
NCT02019706 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of LCI699 in Cushing's Disease Patients
NCT01331239 ·Status: COMPLETED ·Phase: PHASE2
-
Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)
NCT04840693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
NCT03760835 ·Status: RECRUITING ·Phase: PHASE4
-
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
NCT00688987 ·Status: COMPLETED ·Phase: NA